News Announcement

Shukra Pharmaceuticals: Board Meeting Intimation for Quarterly Results

Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve To consider and approve Unaudited financial result for the Quarter ended on 30th June 2026 along with the AuditorsLimited Review Report.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.